Increased Factor VIII Complex in Fulminant Hepatic Failure

Summary

In 30 patients with fulminant hepatic failure (FHF) all three components of the factor VIII complex were significantly increased (VIIIC = 6.43 ± 1.12 u/ml; VIIIRAg = 3.91 ± 0.25 u/ ml; VIIIvWF = 3.89 ± 0.29 u/ml). There was good correlation between all three parameters in control subjects, but only between VIIIRAg and VIIIvWF (r= 0.67; p <0.001) in patients with FHF. VIIIC was significantly higher than VIIIRAg and VIIIvWF. These results suggest that VIIIC and VIIIRAg are increased by different mechanisms in FHF. These processes may include endothelial cell damage, reduced reticuloendothelial system function and lack of production of inactivating substances by the damaged liver.

Platelet adhesion to glass beads was increased in FHF (36.4 ± 5.9% compared to 16.6 ± 2.1%, p <0.01). There was no significant correlation between platelet adhesion and any of the parameters of the factor VIII complex. Thus the increase in platelet adhesion cannot be due to the increase in VIIIvWF in FHF.

Keywords

Factor VIII - fulminant hepatic failure

• References

• 1 Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Haemostas 1977; 4: 40-56
• 2 Bloom AL. Intravascular coagulation and the liver. Br J Haematol 1975; 30: 1-7
• 3 Baele G, Matthijs E, Barbier F. Antihaemophilic factor activity, F-VIII related antigen and von Willebrand factor in hepatic cirrhosis. Acta Haematol 1977; 57: 290-297
• 4 Van Outryve M, Baele G, De Weerdt GA, Barbier F. Antihaemophilic factor A (FVIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis. Scand J Haematol 1973; 11: 148-152
• 5 Bertaglia E, Pelmonte P, Vertolli U, Azzurro M, Martines D. Bleeding in cirrhotic patients. A precipitating factor due to intravascular coagulation or to hepatic failure. Haemostasis 1983; 13: 328-334
• 6 Hoyer LW. The factor VIII complex. Structure and function. Blood 1981; 58: 1-13
• 7 Hellem AJ. Platelet adhesiveness in von Willebrand’s disease. A study with a new modification of the glass bead filter method. Scand J Haematol 1970; 7: 374-382
• 8 Meili EO, Straub PW. Elevation of factor VIII in acute fatal liver necrosis. Thrombos Diathes Haemorrh 1970; 24: 161-174
• 9 Meili EO, Frick PG, Straub PW. Coagulation changes during massive hepatic necrosis due to amanita phalloides poisoning with special reference to antihemophilic globulin. Helv Med Acta 1970; 35: 304-313
• 10 Rubin MH, Weston MJ, Bullock G, Roberts J, Langley PG, White YS, Williams R. Abnormal platelet function and ultrastructure in fulminant hepatic failure. Q J Med 1977; 46: 339-352
• 11 Langley PG, Hughes RD, Williams R. Platelet adhesiveness to glass beads in liver disease. Acta Haematol 1982; 67: 124-127
• 12 Cejka J. Enzyme immunoassay for factor VUI-related antigen. Clin Chem 1982; 28: 1356-1358
• 13 Canalese J, Gove CD, Gimson AES, Wilkinson SP, Wardle EN, Williams R. Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 1982; 23: 265-269
• 14 Brunswig D. Factor VIII related protein - an indicator of Kupffer cell function. In: The reticuloendothelial system and pathogenesis of liver disease ed Liehr H, Grun M. Elsevier; 1980: 295-300
• 15 Milani L, Merkel C, Cavel F, Gasparotto ML, Gatta A. Relationship between plasma levels of factor VIII related antigen and reticuloendothelial function in chronic uremia. Clin Nephrol 1983; 20: 235-238
• 16 Lombardi R, Mannucci PM, Seghatchian MJ, Vicente Garcia V, Coppola R. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol 1981; 49: 61-68
• 17 Trovati M, Tamponi G, Marra S, Lorenzati R, Schinco P, Bazzan M, Vitali S, Cavalot F, Pagano G, Lenti G. Exercise-induced changes of factor VIII complex in healthy subjects and type-1 diabetics: relation between growth hormone and von Willebrand factor increments. Horm Metabol Res 1983; 15: 316-320
• 18 Kopistky RG, Switzer MEP, Williams RS, McKee PA. The basis for the increase in factor VIII procoagulant activity during exercise. Thromb Haemostas 1983; 49:: 53-57
• 19 Chavin SI. Factor VIII - Structure and function in blood clotting. Am J Hematol 1984; 16: 297-306
• 20 Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
• 21 Epstein DJ, Bergum PW, Bajaj SP, Rapapport SI. Radioimmunoassays for protein C and factor X. Am J Clin Pathol 1984; 82: 573-581
• 22 Francis RB, Patch MJ. A functional assay for protein C in human plasma. Thromb Res 1983; 32: 605-613
• 23 Mannucci PM, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 1982; 2: 463-466
• 24 Wegmuller E, Gruninger U, Furlan M, Beck EA, Hodler J, Reubi FC. Factor VIII activity in chronic renal disease. Nephron 1981; 28: 157-162